Concepedia

Yann Quentric

YQ

Statistics

Publications

4

Citations

459

H-Index

4

Active since

2001

Affiliations

AVL (France)(Current)

Servier (France)

Yann Quentric is an author at AVL (France) specializing in medicine, pharmacology, and molecular pharmacology.

Top concepts

Publications per year

2001–2012

4

Publications

4

Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. III. Agonist and Antagonist Properties at Serotonin, 5-HT1 and 5-HT2, Receptor Subtypes

Adrian Newman‐Tancredi, Didier Cussac, Yann Quentric et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 192 citations

The "selective" dopamine D 1 receptor antagonist, SCH23390, is a potent and high efficacy agonist at cloned human serotonin 2C receptors

Mark J. Millan, Adrian Newman‐Tancredi, Yann Quentric et al. · Psychopharmacology · 2001 · 133 citations

, , +7

Characterization of phospholipase C activity at h5-HT 2C compared with h5-HT 2B receptors: influence of novel ligands upon membrane-bound levels of [ 3 H]phosphatidylinositols

Didier Cussac, Adrian Newman‐Tancredi, Yann Quentric et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2002 · 82 citations · Full text

, , +13

Report of the TFOS/ARVO Symposium on Global Treatments for Dry Eye Disease: An Unmet Need

David A. Sullivan, Katherine M. Hammitt, Debra A. Schaumberg et al. · The Ocular Surface · 2012 · 52 citations

, , +5

1–4 of 4